Dr. Reddy's Laboratories, Inc. recalls equate, Allergy Relief D, Fexofenadine HCl 60mg/Antihistamine, Pseudoephedrine HCl 120mg/Nasal Decongestant Extended-Rel
Recalled January 26, 2022 · FDA recall D-0383-2022 · Dr. Reddy's Laboratories
Hazard
Failed Dissolution Specifications · FDA Class III
Units
137,856 boxes
Sold at
Nationwide in the USA
Description
Failed Dissolution Specifications
Product
equate, Allergy Relief D, Fexofenadine HCl 60mg/Antihistamine, Pseudoephedrine HCl 120mg/Nasal Decongestant Extended-Release Tablets USP, a) 20 Extended Release Tablets per box, NDC 49035-273-20, b) 30 Extended Release Tablets per box, NDC 49035-273-30, Distributed by: Walmart Inc., Bentonville, AR 72716, Product of India.
Manufacturer(s)
Dr. Reddy's Laboratories, Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →